My shares that I've sold and the Ones that i still hold have a weighted average basis of sub $2 per share. When I exit the remainder of my position or the majority of the remainder of my position in the 20s I'll take my money and run. My only hope is that we can have positive 113 info well before we are in the production and marketing phase for pona. I find biotechs that go from inventing to "pharmaceutical company" often encounter hiccups that i prefer to be on the sideline for.
Are you seriously comparing ariad a company I love but still doesn't have revenue to apple and IBM. Didn't apple at one point have the largest market cap of any company of all time. Is it reasonable to make that comparison?
News 
Market Data 
Discover 
